Fonte: Marine Drug. Nome do evento: International Symposium on Marine Natural Products. Unidades: ICB, FCFRP
Assuntos: CITOTOXINAS, PRODUTOS NATURAIS, STREPTOMYCES, GLIOMA, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS DO COLON, NEUROGLIA
ABNT
FURTADO, Luciana Costa et al. Cytotoxic ativity of the proteasome inhibitors produced from marine Streptomyces sp. in glioma cells. Marine Drug. Basel: MDPI AG. Disponível em: https://doi.org/10.3390/md18010040. Acesso em: 02 nov. 2024. , 2020APA
Furtado, L. C., Bauermeister, A., Jimenez, P. C., Felício, R. de, Trivella, D. B. B., Lopes, N. P., et al. (2020). Cytotoxic ativity of the proteasome inhibitors produced from marine Streptomyces sp. in glioma cells. Marine Drug. Basel: MDPI AG. doi:10.3390/md18010040NLM
Furtado LC, Bauermeister A, Jimenez PC, Felício R de, Trivella DBB, Lopes NP, Machado Neto JA, Costa-Lotufo LV. Cytotoxic ativity of the proteasome inhibitors produced from marine Streptomyces sp. in glioma cells [Internet]. Marine Drug. 2020 ; 18( 1): 119.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/md18010040Vancouver
Furtado LC, Bauermeister A, Jimenez PC, Felício R de, Trivella DBB, Lopes NP, Machado Neto JA, Costa-Lotufo LV. Cytotoxic ativity of the proteasome inhibitors produced from marine Streptomyces sp. in glioma cells [Internet]. Marine Drug. 2020 ; 18( 1): 119.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/md18010040